世界の製薬会社のR&Dディレクトリ 2022年

出版:Asia Pacific InfoServ 出版年月:2022年5月

Global Pharmaceutical R & D Directory 2022

The Global Pharmaceutical R&D Directory provides a wealth of key business data on trends in pharmaceutical research.

ページ数 450
価格(PDF版) USD 695.00
提供方法 納品形態によって異なります。
種別 英文ディレクトリ

印刷版やCD版の価格設定もございます。詳細はお問合せください。

お問合せ・ご注文    価格・納期について

無料サンプル

About this product

The Global Pharmaceutical R&D Directory provides a wealth of key business data on trends in pharmaceutical research. At a time when investment in R&D is at an all-time high, this essential publication is intended as a strategic reference guide to the important trends in pharmaceutical R&D, as well as providing the means to benchmark your company’s performance. From an examination of global R&D investment and productivity to a breakdown of R&D trends in every major therapeutic class, The R&D Directory provides a comprehensive review of the current R&D environment. The R&D Directory provides essential time-saving business information on:

  • The development pipeline of major companies is analyzed by therapeutic categories and stages
  • Compounds in research by therapeutic class for major companies
  • Number of licensed compounds by therapeutic class and development stage
  • Comparison of companies’ licensed/originated product pipelines
  • Average development time to market, and attrition data
  • Trends in global R&D investment, cost, and culture
  • Number of biotechnology products by development phase, therapeutic class, and type
  • Plus much, much more!

Key Features:

  • Trends in licensing for major pharmaceutical companies
  • R&D Focus for key therapy areas
  • Benchmark development time by phase and success for over dozens of therapeutic categories
  • Comparisons of compounds in research by development stage for dozens of therapeutic areas
  • Analysis of previous year’s pipeline development by stage for all major pharmaceutical companies worldwide.

Contents: Section 1 & 2 of The R&D Directory looks at the trends in R&D expenditure in the major markets, changes in employment patterns and productivity levels in relation to pharmaceutical sales. Section 3 reviews the outsourcing industry and examines its role in pharmaceutical R&D. Section 4 to 9 analyses the trends in R&D by examining the therapeutic focus of selected companies, preclinical compounds, biotechnology compounds, compounds in clinical development for every major therapy class, and licensing activities. Section 10 provides extensive attrition and time-in-development data for the major therapeutic categories. Coverage:

  • Western & Eastern Europe incl. UK
  • USA & Canada
  • South & Central America
  • The Middle East
  • All of Africa
  • All of Asia, including China, India, and Japan
  • Australia & New Zealand.

Based on primary research, the 2-volume The R&D Directory provides the most comprehensive assessment of R&D available! Packed with facts, personalities, charts, and statistics, it is presented as a book and also as a fully searchable PDF edition and CD-ROM.


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com